Evidence map›Paper›PMID 42680978›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Metabolomics Spectral Processing, Data Analysis, and Multiomics Integration Using MetaboAnalyst 6.0.

Zhiqiang Pang, Fiona Hui, Jianguo Xia

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhiqiang Pang *Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
Fiona Hui *Institute of Parasitology, McGill University, Ste-Anne-de-Bellevue, QC, Canada.
Jianguo XiaDepartment of Microbiology and Immunology, McGill University, Montreal, QC, Canada. jeff.xia@mcgill.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MetaboAnalyst is a comprehensive, user-friendly web-based platform for metabolomics data analysis and interpretation. It offers a unified analytical workflow with an intuitive interface designed to streamline data analysis for both targeted and untargeted metabolomics, while supporting integration with other omics datasets. MetaboAnalyst 6.0 represents a significant advancement toward this vision by supporting LC-MS raw spectral processing and MS2 spectral annotation. This chapter builds on our 2019 protocols, which presented 12 step-by-step procedures for statistical and functional analysis using MetaboAnalyst 4.0, with emphasis on targeted metabolomics. Here, we extend that foundation with eight new or substantially revised protocols for MetaboAnalyst 6.0, centered mainly on LC-MS untargeted metabolomics, advanced statistics, and functional analysis. The main topics covered include: Basic Protocol 1: LC-MS raw spectral processing with or without MS2 spectra Basic Protocol 2: MS2 spectral annotation Basic Protocol 3: Functional analysis of untargeted LC-MS metabolomics data Basic Protocol 4: Advanced statistical analysis for studies with multiple factors Basic Protocol 5: Dose-response analysis Basic Protocol 6: Pathway and joint-pathway analysis Basic Protocol 7: Causal analysis Basic Protocol 8: Using MetaboAnalystR for batch processing.

Indexed as

MetabolomicsSoftwareChromatography, LiquidData AnalysisHumansLiquid Chromatography-Mass SpectrometryMetabolomeMultiomicsTandem Mass SpectrometryCausal analysisCompound identificationCovariate adjustmentDose response analysisLC–MSMendelian randomizationMS/MSPathway analysisSpectral processing

Identifiers

PMID42680978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.